However, a recent study based on sequencing of 16S rDNA from the BALF of IPF patients revealed a decreasing trend in the relative abundance of Proteobacteria , and this finding was validated in a BLM-challenged animal model ( Takahashi et al., 2018 ).
← all excerpts
Preliminary exploration of the ability of HUC-MSCs to restore the lung microbiota and related metabolite disorders in IPF treatment: combining 16S sequencing and metabolite analysis.
1
—
—